tirzepatide and iih Idiopathic Intracranial Hypertension (IIH) in a Patient on Tirzepatide: Cure or Culprit? A Case Report A Phase Iv Placebo-Controlled Single
Description
doi: 10.1016/s0140-6736(16)30054-x [DOI] [PMC free article] [PubMed] [Google Scholar] 3
Characteristics and Diagnosis of NAFLD/NASH
15mg dose: 150 units, which definitely requires splitting into two injections or using a 20mg/mL concentration instead
Clinical safety profile Gastrointestinal symptoms
Patients with pre-existing cardiovascular conditions, uncontrolled hypertension, or structural cardiac abnormalities require particularly cautious evaluation, and stimulants may be contraindicated in certain high-risk individuals
Frequently asked questions Will my doctor test for pancreatitis before I start Mounjaro
